Literature DB >> 19951271

Natural history of solitary cerebral cysticercosis cases after albendazole therapy: a longitudinal follow-up study from India.

D Goel1, M Mittal, K K Bansal, A Singhal.   

Abstract

OBJECTIVES: To find out natural course of solitary cerebral cysticercosis (SCC) cases after treating them with 2 weeks albendazole therapy.
MATERIAL AND METHODS: All patients with SCC were treated with 2 weeks of albendazole therapy with follow-up radiological scan at 6 months and 2 years. The evolution of lesion was noted as complete resolution, calcification or persistent active. Antiepileptic drugs (AED) prophylaxis was given for 1 year in patients with complete resolution and for 2 years in calcified lesion, respectively. AED was continued in persistent lesion group till it became calcified or resoluted completely. One-year follow-up was done in all after stopping AED.
RESULTS: Among 345 cases, 226 (65.5%) had complete resolution with very low seizure relapse rate with 1 year of seizure free period on AED treatment. On the contrary, 105 (30.5%) had calcified lesion with high seizure relapse rate after stopping AED treatment with 2 years of seizure free period. Fourteen patients (4%) could not stop their antiepileptic medication at all because of active lesion.
CONCLUSION: Two-third of patients with SCC have favorable outcome with complete resolution and needs short-term AED prophylaxis and the rest one-third requires long AED treatment to prevent seizures.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19951271     DOI: 10.1111/j.1600-0404.2009.01180.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

Review 1.  Diagnosis and treatment of neurocysticercosis.

Authors:  Theodore E Nash; Hector H Garcia
Journal:  Nat Rev Neurol       Date:  2011-09-13       Impact factor: 42.937

Review 2.  Current status and future perspectives on the medical treatment of neurocysticercosis.

Authors:  Isidro Gonzales; Hector H Garcia
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

Review 3.  Clinical manifestations, diagnosis, and treatment of neurocysticercosis.

Authors:  Julio Sotelo
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

4.  Neurocysticercosis.

Authors:  Pratibha Singhi
Journal:  Ther Adv Neurol Disord       Date:  2011-03       Impact factor: 6.570

5.  A longitudinal analysis of albendazole treatment effect on neurocysticercosis cyst evolution using multistate models.

Authors:  Michelle A Montgomery; Marcel Ramos; Elizabeth A Kelvin; Arturo Carpio; Alexander Jaramillo; W Allen Hauser; Hongbin Zhang
Journal:  Trans R Soc Trop Med Hyg       Date:  2019-12-01       Impact factor: 2.184

Review 6.  Drug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis.

Authors:  Willem M Otte; Monika Singla; Josemir W Sander; Gagandeep Singh
Journal:  Neurology       Date:  2012-12-26       Impact factor: 9.910

Review 7.  Pediatric neurocysticercosis: current challenges and future prospects.

Authors:  Pratibha Singhi; Arushi Gahlot Saini
Journal:  Pediatric Health Med Ther       Date:  2016-03-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.